SUSQUEHANNA INTERNATIONAL GROUP, LLP - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 11 filers reported holding ADIAL PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$37,499
-51.8%
180,285
-18.9%
0.00%
Q1 2023$77,799
+301.4%
222,283
+144.3%
0.00%
Q4 2022$19,382
-85.4%
90,996
-8.2%
0.00%
Q2 2022$133,000
+269.4%
99,103
+447.0%
0.00%
Q1 2022$36,000
-85.1%
18,117
-79.8%
0.00%
Q4 2021$242,000
+8.0%
89,784
+72.0%
0.00%
Q3 2021$224,000
+1144.4%
52,200
+280.6%
0.00%
Q1 2020$18,00013,7140.00%
Other shareholders
ADIAL PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,817,454$3,653,0000.07%
CSS LLC/IL 41,300$83,0000.00%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management 35,000$70,0000.00%
CSS LLC/IL 33,900$68,0000.00%
Private Advisor Group, LLC 34,150$69,0000.00%
OPPENHEIMER & CO INC 38,500$77,0000.00%
High Net Worth Advisory Group LLC 1,000$2,0000.00%
VANGUARD GROUP INC 590,852$1,187,0000.00%
UBS Group AG 6,840$14,0000.00%
OSAIC HOLDINGS, INC. 8,321$25,0000.00%
View complete list of ADIAL PHARMACEUTICALS INC shareholders